2016 Influenza Vaccine Production and Distribution Report
Takeaways From The 2016 Flu Market Brief
The 2016 HIDA Influenza Vaccine Production & Distribution Market Brief provides new insights into the flu products supply chain and key information from the sixth annual “HIDA Flu Products Survey” of distributors conducted in May 2016. The survey demonstrates the essential role that distributors will serve during the 2016-2017 flu season by helping healthcare facilities and patients access vaccines, hypodermic supplies, diagnostic tests, and more.
The 2015-2016 influenza season occurred from October 4, 2015 – May 21, 2016. Flu activity was lower and peaked later compared to previous seasons, ultimately peaking in mid-March. Influenza A(H1N1)pdm09 viruses predominated overall, but influenza A(H3N2) viruses were common through December, while influenza B viruses were more commonly identified from mid-April through mid-May. The healthcare supply chain demonstrated flexibility and efficiency through 24-48 hour delivery and logistical expertise to ensure healthcare providers were well-supplied throughout the flu season.
Additionally, the 2016 HIDA Influenza Vaccine Production & Distribution Market Brief provides key information on:
Flu vaccine production, supply, and allocation
Patient and physician vaccination trends
Managing influenza with diagnostic resources
Manufacturing and distribution processes
2016 Medicare reimbursements
Quality reporting measures related to influenza vaccination
Vaccine effectiveness trends.
Who Should Read This Report
This report is intended for several key audiences: senior sales, marketing, and strategy executives of healthcare distribution and manufacturing companies, and healthcare sales staff in the field. Stakeholders in the influenza vaccine supply chain and government agencies responsible for the public health and oversight of the production and distribution of influenza vaccines will also find this report of interest.
Please note: the online download version of this report is for a global site license.